Multinational companies continue to produce and sell unregulated antibiotics in India, worsening the problem of antimicrobial resistance in the country and impeding efforts to fight drug resistance globally, a UK study said.
The report, to be made public on Monday by researchers at Queen Mary University of London and Newcastle University, said millions of antibiotic pills in the Indian market have not been regulated in India, the UK or US. The research was published in the British Journal of Clinical Pharmacology.
ALSO READ:Govt To Take Action Against Chemists For Selling Antibiotics Without Prescription
Reuters/Representational Image
Comments are closed